Lewis H. Titterton Jr.

Director, Anixa Biosciences, July 15 to October 23, 2026
Open-market purchases
$101,9544 transactions
Open-market sales
$00 transactions
Net
+$101,954Purchases minus sales
Companies
14 Form 4 filings

Companies

Net, last reported holding
ANIX Anixa BiosciencesDirector, last trade Oct 23
+$101,9541,054,003 shares

Purchases and sales

4 transactions
CompanyTransactionSharesPriceAmountDate
ANIXAnixa Biosciences
Purchase
8,000
$2.98
$23,840
ANIXAnixa Biosciences
Purchase
10,000
$2.73
$27,300
ANIXAnixa Biosciences
Purchase
12,000
$3.47
$41,640
ANIXAnixa Biosciences
Purchase
2,797
$3.28
$9,174
How to read
Purchases and sales are open-market transactions only (codes P and S). Partial trades in the same filing are combined on one row, and the price is a weighted average.